Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation
The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in pa...
Saved in:
Main Author: | E. V. Artamonova (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Video-assisted surgery in the treatment of early corpus uteri cancer
by: T. M. Kochoyan, et al.
Published: (2014) -
Tumor markers in the diagnosis of cancer of the corpus uteri (a review of literature)
by: D. B. Olkin, et al.
Published: (2014) -
Laparoscopy in the treatment of cancer of the corpus uteri in patients with metabolic syndrome. A case report
by: A. I. Berishvili, et al.
Published: (2015) -
Mass spectrometry is a new approach to diagnosing adenomyosis and cancer of the corpus uteri
by: A. V. Sorokina, et al.
Published: (2014) -
Impact of the morphological signs of Stage II corpus uteri cancer on the occurrence of recurrences and metastases
by: E. A. Mustafina, et al.
Published: (2014)